Noor Ul Husnain, Farheen Farrukh, Zulekha Siddique
The epidemic of coronavirus malady 2019 brought about by extreme intense respiratory condition coronavirus 2 was diffusion all through world. In spite of the fact that sub-atomic analytic tests are the highest excellence level for COVID‐19, serological testing is rising as the possible reconnaissance instrument, notwithstanding their integral job in COVID‐19 diagnostics. Our current research was conducted at Mayo Hospital, Lahore from March 2020 to July 2020. Although quantitative serological testing certainly offers more influential points of interest than subjective calculations, here is still frequently the mystery about serological analysis today and what maximum effective quantitative calculations might do. The iFlash1850 CLIA analyzer for anti-SARS CoV‐2 antibodies IgM and IgG tested sixty-one COVID‐19 patients and 64 cases from the sample set. Both COVID‐19 patients were treated at Services Hospital Lahore and had strong nasopharyngeal polymerase chain reverse transcription reaction. The most raised affectability through the very great particularity execution was reached at cutoff estimation of 10.0 AU/mL for IgM furthermore, of 7.1 for IgG antibodies, thus close to the producer's cutoff estimations of 10 AU/mL for both isotypes. The beneficiary working trademark bends appeared region under bend estimates of 0.919 and 0.983 for anti‐SARS CoV‐2 antibodies IgM what's more, IgG, separately. iFlash1800 CLIA analyzer has indicated exceptionally precise outcomes for anti‐SARS‐CoV‐2 antibodies profile in addition might be viewed as an incredible apparatus for COVID‐19 diagnostics. Keywords: Anti-Sars-Cov-2, Antibodies.